The CDC has released a new analysis that may be a benchmark for women’s behavior regarding pelvic exams before ACOG made a sea change in guidance on when to perform the tests.
©EtiAmmos - shutterstock.com
The Centers for Disease Control and Prevention (CDC) has released a new analysis that may be a benchmark for women’s behavior regarding pelvic exams before the American College of Obstetricians and Gynecologists (ACOG) made a sea change in guidance on when to perform the tests. Published in an NCHS Data Brief, the report spans a 19-year period and reveals trends in compliance with annual testing related to patient age, race, and socioeconomic status.
Published in an NCHS Data Brief, the report is based on interview data from more than 10,000 women aged 15 to 44 in the National Survey of Family Growth (NSFG). The NSFG is a nationally representative survey of US men and women aged 15 to 44 designed to gather data on fertility, cohabitation, marriage, divorce, infertility, use of contraception and general and reproductive health.
The authors looked at trends overall and by age from 1988 to 2017 in receipt of pelvic exams in the past year and differences by Hispanic origin and race, education, poverty status, and health insurance status for 2015 to 2017. Percentages were compared using two-tailed ttests at the 0.05 level and no adjustments were made for multiple comparisons.
In 2012, ACOG issued a Committee Opinion recommending annual pelvic exams for women aged 21 and over as part of the well-woman visit. The guidance was changed in 2018, when the organization issued a Committee Opinion advising that the test be performed when indicated by medical history or symptoms.
The key findings of the CDC analysis are as follows:
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More